1745 sensitivitv (for example, skin eruption), but eosinophil counts were not available. He died about 72 hours later. No other cytotoxic agents had been administered.
Discussion
Transient abnormalities of liver function tests are recognised side effects of dacarbazine treatment." To our knowledge acute liver failure due to vascular occlusion in patients receiving single-agent chemotherapy with dacarbazine has been reported in only one case.2 Our patients showed broadly similar clinical, laboratory, and histological features. The temporal relation to dacarbazine treatment, the absence of any other identifiable cause, and the histological dissimilarity to the rare hepatic lesions attributed to chlorpromazine and amitryptiline incriminate dacarbazine. A synergistic adverse drug reaction cannot, however, be excluded. The eosinophilia in case 1, which suggests a drug reaction, was transient and preceded clinical deterioration. Eosinophil counts during each course of treatment may therefore be valuable in the early detection of liver damage.
One of us (PJS) reviewed the histology of a further patient receiving dacarbazine in whom hepatic vein thrombosis had led to the Budd-Chiari syndrome. We are also aware of five other deaths after hepatic vascular occlusions in patients receiving dacarbazine as part of multiple-agent chemotherapy3 4 
Ophthalmological examination including rose bengal staining confirmed sicca syndrome, and bilateral active scleritis with scleral thinning was also noted. Also the right retina showed a background pigmentary disturbance and several large fresh soft white exudates randomly distributed over the posterior pole. No retinal changes were seen in the left eye. Her right visual acuity was 6/18. At an ophthalmic examination six months earlier both retinae were normal and the right visual acuity 6/9.
Investigations showed haemoglobin concentration 14 5 g/dl, viscosity 223 mPa s (223 cP), rheumatoid factor titre 1/2560, and antinuclear factor titre 1/40. C3 and C4 values were normal, though there was evidence of high concentrations of circulating immune complexes: anticomplementary activity 1/32 (normal 1/2). Clq binding was 65% (normal 20%0), platelet aggregation 1/512 (normal 1/16), and cryoglobulins positive. Chest radiography showed extensive old tuberculosis but results of sputum culture and microscopy were negative. The patient was treated with bed rest, non-steroidal anti-inflammatory drugs, local hypromellose and cortisone eye drops. After two months there was a noticeable improvement, and by six months the retinal changes had disappeared and visual acuity had improved. Her systemic rheumatoid disease also became less active, she gained weight, and tests for circulating immune complexes became negative.
Retinal vasculitis may complicate many systemic diseases,' including tuberculosis, sarcoidosis, Behcet's syndrome, and systemic lupus erythematosus. In a recent review2 of 17 patients with retinal vasculitis, immune complexes were found in the sera of 13 and rheumatoid factor was present in four.
Vasculitis complicating rheumatoid arthritis3 4 usually occurs in nodular disease, with high titres of classical IgM rheumatoid factor and raised concentrations of circulating immune complexes. Infarcts in nailfold capillaries are often seen and weight loss and general malaise are common. Our patient had all these features, including circulating immune complexes detected by four different assays. The timing of the retinal disease and the observed rapid clinical improvement that accompanied the fall in concentrations of circulating immune complexes suggest that the retinal changes were a direct consequence of her active rheumatoid disease.
We suggest that the retina should be examined for evidence of vasculitis in rheumatoid disease, and that vasculitis should be added to the list of ocular complications of rheumatoid arthritis.5 Introduction Mania occurring in the puerperium, though rare, can present important problems of management, particularly when the mother continues to breast feed. We report a case of puerperal psychosis treated with haloperidol in which substantial amounts of the drug were secreted in breast milk and ingested by the infant. There was no evidence, however, of any long-term effect on the infant's development. MRC 38 Palmerston Place, Edinburgh EH12 5BJ J K PRIME, RGN, SCM, health visitor Case report A mother delivered a live girl weighing 2660 g at 39 week's gestation after induction of labour with an intravenous infusion of oxytocin. Apgar scores were 9 at one and five minutes. Pregnancy had been uneventful and there was no history of psychiatric illness. The immediate postnatal period progressed normally; breast feeding was established and mother and child were well. On the 16th day the mother was found by the health visitor to be tense, anxious, and talking continuously. The general practitioner diagnosed puerperal psychosis and prescribed chlorpromazine 25 mg four times daily. There was no improvement, and on the 20th day mother and baby were admitted to hospital. The baby was progressing well and breast feeding was continued under supervision. The mother was deluded, euphoric, and overactive. Puerperal hypomania was diagnosed and treatment begun with oral haloperidol 5 mg twice daily.
Samples of the mother's plasma and breast milk and the baby's urine were collected on the first, sixth, seventh, and 21st days of treatment. Only one of the urine samples was suitable for assay. The concentration of haloperidol in these samples was measured by radioimmunoassay (sensitivity 0-5 ,ug/l). The table gives the results.
Four weeks after the birth mother was improving, though still very tense and anxious. The baby did not appear to be sedated and was feeding well. Haloperidol was stopped in the sixth week after birth and 
